TILT Biotherapeutics was highlighted as one of the key companies developing oncolytic viruses in an interesting report entiteled ” A New Wave of Cancer Therapies: Local Tumor Immuno-Rx Drives Distant Effects”, published by Piper Jaffray & Co.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
13th November 2023
Investival Showcase 2023
London, England
6-8th December 2023
ESMO IO
Geneva, Switzerland
8-10th January 2024
Biotech Showcase
San Francisco, USA
28-29th February 2024
Sachs Annual European Life Sciences CEO Forum
Zurich, Switzerland
10-12 March 2024
SITC
Miami, USA
18-20th March 2024
BIO-Europe
Barcelona, Spain